OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
July 09, 2015
Sepha's VisionScan Max can leak-test full production batches of blister packs.
Teva has launched the generic version of almotriptan malate (Axert), 6.25 mg and 12.5 mg, in the United States.
July 07, 2015
Vacuum-conveying conditions for powders and other free-flowing solid forms can be simulated in Volkmann's new laboratory.
A study now underway on vaccine manufacturing examines the effects of focusing on consistency during manufacturing, instead of post-production testing.
FDA orders unapproved prescription ear drop products with active ingredients removed from the market.
July 06, 2015
Biogen plans to build a biologics manufacturing plant in northwest Switzerland using next-generation technologies to create efficiency and sustainability.
July 02, 2015
Electronic pharmaceutical tablet counters meet demands for accuracy, flexibility, speed, compact size, easy cleanability, and quick changeover.
Anton Paar’s MCP polarimeters are now designed with a new LED light source and optional integrated air pump to clean and dry sample cells.
Delivery systems that allow drugs to be administered as liquids, but to form gel within the eye, promise to improve efficacy and patient compliance.
The addition of a new manufacturing line at Lonza’s Portsmouth, NH site enables Alexion to add dedicated product supply for 10 years.